Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Teplinisky, Eleanora
GOG-3026, NCT03673124: Ribociclib and Letrozole Treatment in Ovarian Cancer	Active, not recruiting	2	51	US	Ribociclib, Letrozole	Gynecologic Oncology Group, Novartis	Low Grade Serous Carcinoma	12/23	12/24
Bessada, Kasey
GOG-3026, NCT03673124: Ribociclib and Letrozole Treatment in Ovarian Cancer	Active, not recruiting	2	51	US	Ribociclib, Letrozole	Gynecologic Oncology Group, Novartis	Low Grade Serous Carcinoma	12/23	12/24